Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02367040 |
| Title | Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL) |
| Acronym | CHRONOS-3 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | TUR | SVK | ROU | POL | NZL | LTU | ITA | IRL | HUN | GRC | FRA | ESP | DEU | BRA | BGR | BEL | AUT | AUS | ARG |